Suzano S.A. (ADR) stock (US86964W1027): UK regulator clears Kimberly-Clark tissue JV, focus on Brazil-listed pulp group

Suzano S.A. (ADR) is in focus after the UK Competition and Markets Authority cleared its planned USD 3.4 billion tissue joint venture with Kimberly-Clark, while the Brazil-based pulp and paper group continues to trade actively on the NYSE via its ADRs.

Suzano S.A. (ADR) is drawing renewed attention on Thursday as the Brazil-based pulp and paper producer moves closer to forming a new global tissue player with Kimberly-Clark following UK antitrust clearance for their planned USD 3.4 billion joint venture, while its American depositary receipts continue to trade on the New York Stock Exchange and in São Paulo under the home ticker SUZB.

According to the UK Competition and Markets Authority (CMA), the regulator cleared the proposed Kimberly-Clark and Suzano tissue joint venture after reviewing the impact on the United Kingdom tissue and personal care markets, removing a key regulatory hurdle for the deal as set out in its published decision in 2026. The agreement, first announced in June 2025, envisages Suzano acquiring a 51% stake in the new company for about USD 1.73 billion in cash, while Kimberly-Clark will hold the remaining 49%, giving Suzano a controlling interest in the business that will combine certain tissue assets and operations contributed by Kimberly-Clark into a new entity.

The stock traded at levels close to its recent range in Brazilian real on the B3 exchange in São Paulo on 05/28/2026, where Suzano remains a major constituent of the local equity market, while its ADRs provide US investors exposure to the same underlying Brazilian shares via the NYSE listing under the symbol SUZ. In Germany, Suzano can also be accessed by retail investors through trading venues such as Tradegate and Frankfurt that quote the ADRs in euro terms alongside the primary US and Brazilian listings, helping bridge liquidity between European and Latin American markets for this issuer.

As of: 05/28/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: SUZ
• Sector/industry: Pulp and paper, packaging, and tissue products
• Headquarters/country: São Paulo, Brazil
• Core markets: Brazil, Europe, North America, and Asia for pulp, paper, and hygiene products
• Key revenue drivers: Bleached eucalyptus kraft pulp, printing and writing paper, packaging board, and tissue and hygiene product demand linked to global consumption and industrial activity
• Home exchange/listing venue: B3 São Paulo (SUZB3) and NYSE (SUZ ADR)
• Trading currency: BRL for domestic shares; USD for ADRs

Suzano S.A. (ADR): core business model

Suzano S.A. operates as a vertically integrated Brazilian producer of eucalyptus-based pulp, paper, and related packaging and tissue products, with earnings heavily influenced by benchmark pulp prices, foreign-exchange movements between the Brazilian real and the US dollar, and long-term demand for sustainable fiber-based materials.

Industry trends and competitive position

The global pulp and paper industry has been reshaped in recent years by shifting consumption patterns, with graphic paper usage under structural pressure from digitalization while demand for tissue, packaging, and cellulose-based specialty products continues to expand, particularly in emerging markets and in e-commerce-driven packaging segments. Suzano competes with major international pulp and tissue producers by leveraging Brazil's cost-advantaged eucalyptus plantations, large-scale industrial facilities, and export infrastructure, allowing the group to position itself as a low-cost supplier to markets in Europe, North America, and Asia that seek reliable, sustainable fiber sources and increasingly favor certified forestry practices.

Within the tissue and hygiene segment, the planned joint venture with Kimberly-Clark is designed to create a more focused vehicle for Suzano to participate in branded and private-label tissue markets alongside an established multinational consumer products partner, potentially enhancing its downstream presence beyond its traditional role as a bulk pulp supplier. By integrating selected Kimberly-Clark assets into a jointly controlled entity, Suzano aims to diversify further into value-added products and reduce its exposure to pulp price cycles, while the CMA's clearance in the United Kingdom indicates that regulators currently see no material competition concerns that would block execution of the transaction in that jurisdiction.

Conclusion

The CMA's approval of the Kimberly-Clark tissue joint venture removes an important regulatory condition for Suzano and underscores the Brazilian group's ambition to rebalance its portfolio toward downstream hygiene and tissue markets alongside its core export pulp activities. For investors tracking the ADRs on the NYSE and the domestic shares on B3 in São Paulo, the progress of this transaction, together with broader pulp price and currency dynamics, will remain central variables for assessing the future earnings profile and strategic positioning of Suzano S.A. within the global fiber and packaging value chain.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.